Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | MITF | O75030 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.54 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.54 |
| ▸ | PPARA | Q07869 | 5/20 | 0.53 |
| ▸ | PPARG | P37231 | 4/20 | 0.53 |
| ▸ | CETP | P11597 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | LPL | P06858 | 1/20 | 0.47 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28333197 | 0.93 | ALDH1A1 (0.61) | ALDH1A1SMN1; SMN2MEN1MITFGAA | |
| SCHEMBL28547948 | 0.89 | PPARA (0.63) | PPARAPPARGCETPLPLLIPG | |
| SCHEMBL27830388 | 0.89 | PPARA (0.63) | PPARAPPARGCETPLPLLIPG | |
| SCHEMBL176242 | 0.89 | PPARA (0.63) | PPARAPPARGCETPLPLLIPG | |
| SCHEMBL9819438 | 0.89 | PPARA (0.63) | PPARAPPARGCETPLPLLIPG | |
| SCHEMBL29693068 | 0.89 | PPARA (0.63) | PPARAPPARGCETPLPLLIPG | |
| SCHEMBL23085167 | 0.88 | PPARA (0.62) | PPARAPPARGCETPLPLLIPG | |
| SCHEMBL29959530 | 0.88 | PPARA (0.62) | PPARAPPARGCETPLPLLIPG | |
| SCHEMBL8356790 | 0.88 | ALDH1A1 (0.61) | ALDH1A1SMN1; SMN2MEN1MITFGAA | |
| SCHEMBL10624215 | 0.88 | PPARA (0.62) | PPARAPPARGCETPLPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9234109-B2 | Phase change inks | XEROX CORPORATION (US) | 2016-01-12 | — | — | US | disclosed |
| US-9234109-B2 | Phase change inks | XEROX CORPORATION (US) | 2016-01-12 | — | — | US | disclosed |
| EP-2169016-B1 | Phase change inks | XEROX CORP (US) | 2012-02-29 | — | — | EP | disclosed |
| US-20100080922-A1 | PHASE CHANGE INKS | XEROX CORPORATION (US) | 2010-04-01 | — | — | US | disclosed |
| EP-2169016-A1 | Phase change inks | Xerox Corporation (US) | 2010-03-31 | — | — | EP | disclosed |